Amgen (AMGN) Gross Margin (2009 - 2026)

Amgen's Gross Margin history runs 18 years deep, the most recent figure standing at 68.16% for Q1 2026.

• In Q1 2026, Gross Margin rose 458.0% year-over-year to 68.16%; the TTM figure through Mar 2026 stood at 104.96% (up 3247.0% YoY), while the FY2025 annual figure was 96.43%, up 3490.0% from the prior year.
• Gross Margin was 68.16% for Q1 2026 at Amgen, down from 178.54% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 178.54% in Q4 2025 to a low of 280.61% in Q4 2022.
• Historically, Gross Margin has averaged 60.67% across 5 years, with a median of 73.84% in 2023.
• The sharpest annual moves came in 2022 and 2023: Gross Margin tumbled 44696 bps in 2022, then soared 34264 bps in 2023.
• A 5-year view of Gross Margin shows it stood at 280.61% in 2022, then surged by 122 bps to 62.03% in 2023, then rose by 6 bps to 65.75% in 2024, then surged by 172 bps to 178.54% in 2025, then sank by 62 bps to 68.16% in 2026.
• The last three Gross Margin figures came in at 68.16% (Q1 2026), 178.54% (Q4 2025), and 67.75% (Q3 2025), per Business Quant data.